早产临产后孕激素维持治疗延长妊娠的系统评价与Meta分析
该系统评价与Meta分析纳入13项随机对照试验共1722名孕16+0至37+0周发生早产临产的孕妇,评估孕激素维持治疗的效果。孕激素维持治疗组潜伏期较对照组延长4.32天(MD 4.32,95%CI 0.40-8.24),新生儿出生体重更高(MD 124.25 g,95%CI 8.99-239.51)。但仅分析低偏倚风险研究(5项RCT,591名孕妇)时,潜伏期延长未达统计学显著(MD 2.44天,95%CI -4.55至9.42)。
要点
- 孕激素维持治疗组潜伏期较对照组延长4.32天(MD 4.32,95%CI 0.40-8.24)。
- 孕激素维持治疗组新生儿出生体重较对照组高124.25 g(MD 124.25 g,95%CI 8.99-239.51)。
- 仅低偏倚风险研究(5项RCT,591名孕妇)分析时潜伏期延长未达统计学显著(MD 2.44天,95%CI -4.55至9.42)。
核心结论
- 早产临产后孕激素维持治疗对延长潜伏期可能有适度效果,但仅分析低偏倚风险研究时该效果未得到证实。
- 作者高度推荐通过进一步研究验证,最好采用个体患者数据Meta分析。
研究设计与样本
- 系统评价与Meta分析,检索Central Cochrane、Ovid Embase、Ovid Medline及临床试验数据库。
- 纳入13项随机对照试验,共1722名孕16+0至37+0周发生早产临产的孕妇,比较孕激素维持治疗与对照组。
- 主要结局为潜伏期天数,次要母婴结局与早产研究核心结局集一致,并广泛评估数据可信度与偏倚风险。
主要发现
- 孕激素维持治疗组潜伏期较对照组延长4.32天(MD 4.32,95%CI 0.40-8.24)。
- 孕激素维持治疗组新生儿出生体重较对照组高124.25 g(MD 124.25 g,95%CI 8.99-239.51)。
- 其他围产期结局未见差异。
- 仅分析低偏倚风险研究(5项RCT,591名孕妇)时,潜伏期延长未达统计学显著(MD 2.44天,95%CI -4.55至9.42)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 仅分析低偏倚风险研究(5项RCT,591名孕妇)时,潜伏期延长未达统计学显著(MD 2.44天,95%CI -4.55至9.42)。
- 作者高度推荐通过进一步研究验证,最好采用个体患者数据Meta分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence for progestogen maintenance therapy after an episode of preterm labour (PTL) is contradictory. OBJECTIVES: To assess effectiveness of progestogen maintenance therapy after an episode of PTL. SEARCH STRATEGY: An electronic search in Central Cochrane, Ovid Embase, Ovid Medline and clinical trial databases was performed. SELECTION CRITERIA: Randomised controlled trials (RCT) investigating women between 16+0 and 37+0 weeks of gestation with an episode of PTL who were treated with progestogen maintenance therapy compared with a control group. DATA COLLECTION AND ANALYSIS: Systematic review and meta-analysis were conducted. The primary outcome was latency time in days. Secondary neonatal and maternal outcomes are consistent with the core outcome set for preterm birth studies. Studies were extensively assessed for data trustworthiness (integrity) and risk of bias. MAIN RESULTS: Thirteen RCT (1722 women) were included. Progestogen maintenance therapy demonstrated a longer latency time of 4.32 days compared with controls (mean difference [MD] 4.32, 95% CI 0.40-8.24) and neonates were born with a higher birthweight (MD 124.25 g, 95% CI 8.99-239.51). No differences were found for other perinatal outcomes. However, when analysing studies with low risk of bias only (five RCT, 591 women), a significantly longer latency time could not be shown (MD 2.44 days; 95% CI -4.55 to 9.42). CONCLUSIONS: Progestogen maintenance therapy after PTL might have a modest effect on prolongation of latency time. When analysing low risk of bias studies only, this effect was not demonstrated. Validation through further research, preferably by an individual patient data meta-analysis is highly recommended.
引用
- Breuking SH, De Ruigh AA, Hermans FJR, et al. Progestogen maintenance therapy for prolongation of pregnancy after an episode of preterm labour: A systematic review and meta-analysis. BJOG. 2023. PMID: 37077041. doi:10.1111/1471-0528.17499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。